Product Information

TERAZOSIN 1 MG CAPSULE is a generic product labeled by Bionpharma Inc., priced at $0.1016 per EA under NDC 69452033020. Its NADAC has been published 116 times since Sep 4, 2024.

FDA first approved this application on Jul 28, 2000. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TERAZOSIN 1 MG CAPSULE

Terazosin
$0.1016per EA

Strength

1 mg/1

Manufacturer

Bionpharma Inc.

NDC

69452033020

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

TERAZOSIN HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA075667

FDA Approved

7/28/2000

TE Code

AB

On Market Since

3/11/2024

Pharmacological Classes

Adrenergic alpha-Antagonists
alpha-Adrenergic Blocker

Price Statistics

The NADAC for TERAZOSIN 1 MG CAPSULE has been published 116 times since Sep 4, 2024, and over the history we have for it it has declined 20.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1016 per EA
All-time high$0.1469 (Mar 12, 2025)
All-time low$0.1016 (Nov 18, 2026)
52-week high$0.1252
52-week low$0.1016
Median price$0.1211
Average price$0.1256
Largest weekly change-9.1% (Jun 17, 2026)
Weeks tracked116
Tracking sinceSep 4, 2024

Price History

1W

-0.3%

1M

-6.2%

3M

-7.6%

6M

-15.7%

1Y

-15.4%

3Y

N/A

5Y

N/A

All

-20.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TERAZOSIN 1 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for TERAZOSIN 1 MG CAPSULE, manufactured by Bionpharma Inc., is $0.1016 per EA (NDC 69452033020), effective Nov 18, 2026.

How has the price of TERAZOSIN 1 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for TERAZOSIN 1 MG CAPSULE has declined 20.2%. It has been tracked across 116 weekly CMS publications since Sep 4, 2024.

What are the highest and lowest recorded NADAC prices for TERAZOSIN 1 MG CAPSULE?

Since Sep 4, 2024, the NADAC for TERAZOSIN 1 MG CAPSULE has ranged from a low of $0.1016 (Nov 18, 2026) to a high of $0.1469 (Mar 12, 2025), with a median of $0.1211 per EA.

Are there cheaper alternatives to TERAZOSIN 1 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TERAZOSIN 1 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures TERAZOSIN 1 MG CAPSULE?

TERAZOSIN 1 MG CAPSULE (NDC 69452033020) is labeled by Bionpharma Inc., and CMS classifies it as a generic product.